A single-center, randomized, double-blind, placebo-controlled Phase I clinical tolerance, pharmacokinetics and pharmacodynamics study of hypodermic injection of pegfilgrastin (PEG - G-CSF) with single doses in healthy volunteers.

Trial Profile

A single-center, randomized, double-blind, placebo-controlled Phase I clinical tolerance, pharmacokinetics and pharmacodynamics study of hypodermic injection of pegfilgrastin (PEG - G-CSF) with single doses in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Sep 2016

At a glance

  • Drugs Pegfilgrastim (Primary)
  • Indications Leucopenia
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 24 Sep 2016 Status changed from recruiting to completed.
    • 02 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top